Lung meetings & conferences

26th Annual North American Cystic Fibrosis Conference

October 11-13, 2012 Orlando, Florida

World Allergy Organization International Scientific Conference

World Allergy Organization International Scientific Conference (WISC 2012) Hyderabad, India, 6-9 December 2012. The theme of the Conference is Severe Allergies, Severe Asthma: New Strategies for Treatment and Prevention.

Building on the success of the first WISC in Dubai, December 2010, WAO is excited to launch its second theme-based scientific conference. With 24 Postgraduate Courses on a wide range of topics, Plenary Sessions, Parallel Symposia, Keynote Lectures, Poster Sessions and Highlights in Immunotherapy, WISC 2012 will be a multidisciplinary forum for allergists, pulmonologists, ENTs, dermatologists, internists, pediatricians, gastroenterologists, clinical immunologists and primary care physicians.

WAO is organizing these focused, theme-based scientific conferences in recognition of:

The increasing prevalence and more complex forms of allergic diseases and asthma worldwide, especially in children
The need to create a more integrated approach to the diagnosis and management of allergic diseases
The need to expand the knowledge and practice of allergy and provide more practical knowledge to young professionals

The 2012 Conference on Severe Allergies, Severe Asthma: New Strategies for Treatment and Prevention will provide a forum for the most useful combination of latest research, review of current theory and practice, and hands-on, problem-based learning. Our aim is that participants gain insight into the most effective advances in the diagnosis and management of complex and severe allergies and asthma and in their preventative strategies.

Contact Us

General Inquiries
WISC@worldallergy.org

Registration
WISCregistration@worldallergy.org

World Allergy Organization
555 East Wells Street, Suite 1100
Milwaukee, WI 53202
United States
Tel: +1 414 276 1791
Fax: +1 414 276 3349

6th Forum on Respiratory Tract Infections

November 28-30 2012 Barcelona, Spain

The 6th RTI Forum in the series is now proposed in response to important advances and novel issues in the matters of epidemiological, diagnostic and therapeutic events, including significant new agents, both anti-microbial and adjunctive, early recognition of bacterial disease (and rapid pathogen identification) and preventative vaccines. Most of these will be approaching the clinical interface within the next 2-3 years. They urgently merit both objective interdisciplinary evaluation and wider dissemination to leaders in their clinical application. The 6th RTI Forum offers a unique opportunity to discuss these issue with experts in respiratory Infection in an intimate and informal atmosphere and we hope to welcome you in Barcelona!

Topics for RTI 2012 Forum include:

The continued role of Ps aeruginosa in broncho-pulmonary disease.
The “Last” antibiotic decade (the possible future without antibiotics)
The re-emergence of preventable respiratory disease: pertussis, measles, varicella, mumps
Unanswered questions in AECB – what data must new trials provide
Inhaled therapy – an expanding future?
Nosocomial MRSA pneumonia
CA-MRSA
Ventilator-associated-pneumonia (or VA tracheitis)
Tuberculosis / MDR-TB: non-MTB mycobacteria in RTI
Current role of pneumococcal vaccines: efficacies and deficiencies?
Community acquired pneumonia
Healthcare Associated pneumonia
Development of the vancomycins
Aspergillosis
Influenza then and now
Influenza vaccines (after Bird flu where next)
Faculty Advisory Board: Any Questions?

Secretariat - Publicreations
74, Bd d’Italie, Monte Carlo - MC98000 (Monaco)
Ph.: +377 9797 3555 - Fax: +377 9797 3550
Email: rti@publicreations.com

The Lung – a Pivotal Player in Systemic Inflammatory Disorders

June 11-12, 2012 Solna, Sweden

As representatives of the Executive Committee and Advisory Board of this symposium we are happy to invite you to participate in this unique symposium on systemic inflammatory disorders. It is arranged by representatives from both clinic and research, and by specialists in pulmonary medicine, rheumatology and neurology enabling fruitful information and discussions on general topics as well as on specific issues. The high quality of the meeting is reflected by the use of the trade mark “Karolinska Institutet Conferences”, and internationally well recognized speakers further guarantee that interesting data will be presented.

The symposium is arranged as a result of recent data on how smoking and genetic factors have a great impact not only on the lungs but also on other organs affected in systemic inflammatory disorders. These findings call for more intensive collaborations in the future between clinicians representing different specialties’ and for research of truly translational character.

Introductory speeches will be given to inform about common clinical findings which may reflect lung involvement in systemic disorders, and how they can be established. Smoking and co-morbidity in systemic inflammatory disorders will be discussed, and the role of interstitial lung involvement in myositis, rheumatoid arthritis and multiple sclerosis will be elucidated. Can smoking related changes in the lung trigger joint inflammation, or increase the risk of getting myositis or MS? Another topic is the genetic and possible etiological background in sarcoidosis.

Up-to-date treatment of interstitial lung involvement, pros and cons, and the effects of smoking on treatment will be debated followed by an overview of failures and successes of smoking cessation programs.

You will also at a poster-viewing session be given the opportunity to informally discuss your own abstract. Can you really afford not to participate?

Congrex Sweden AB
Attn: The Lung

Telephone/fax
T: +46 8 459 66 00
F: +46 8 661 91 25

General requests
thelung2012@congrex.com
Registration and hotel matters
thelung2012.registration@congrex.com

COPD8 International Conference on Chronic Obstructive Pulmonary Disease

20th - 22nd June 2012 Birmingham, United Kingdom

COPD8 is an International Conference aimed at the breadth of the COPD spectrum from basic science through to clinical practice and what people living with the condition need and want. COPD8 will provide new and interesting information for all delegates and encourage lively debate and discussion.

If you have any queries about the conference, please contact:

COPD8 Conference Managers
Executive Business Support Ltd
City Wharf, Davidson Road
Lichfield
Staffordshire
WS14 9DZ

Tel: +44 (0) 845 226 3068
Fax: +44 (0) 121 355 2420
Email: info@copdconferences.org

 55th Annual Thomas L. Petty Aspen Lung Conference

“Mechanics and Mechanisms of Pulmonary Hypertension”

June 6-9, 2012 Aspen, Colorado

The theme of the 55th Meeting of the Thomas L. Petty Aspen Lung Conference is “Mechanics and Mechanisms of Pulmonary Hypertension”. Emphasizing the integration of basic, translational and clinical sciences, the meeting will focus on the utilization of new strategies and technologies to investigate the pathogenesis, treatments and outcomes of pulmonary hypertension. Anchored by twelve “state-of-the-art” presentations delivered by international experts with accompanying abstract presentations, the thematic sessions will address epidemiology, progenitor cell biology, the role of inflammation, genetic somatic mutations and epigenetics, the impact of right ventricle (RV) dysfunction and RV-pulmonary artery coupling, the etiology and implication of PAH in WHO class III disease and prospects for novel disease modifying and preventive therapies. The Conference Summary will be presented by Werner Seeger, M.D., Professor of Medicine, Chief of the Department of Internal Medicine at the University Giessen Hospital, Germany. Dr. Seeger is Chairman of the Lung Center, and the Director of the Max Planck Institute for Heart and Lung Research and one of the world’s preeminent experts in the field of pulmonary vascular disease.

For more information, contact:

Todd Bull, M.D., c/o Jeanne Cleary
Thomas L. Petty Aspen Lung Conference
Anschutz Medical Campus, Research 2, Box C272, 9th Floor
12700 East 19th Avenue, Aurora, CO 80045
Phone: (303) 358-2797. Fax: (720) 851-1034. E-Mail:
Jeanne.Cleary@ucdenver.edu

or visit our website at
www.aspenlungconference.org
 

15th World Conference on Lung Cancer

October 27-31, 2012 Sydney, Australia

At the 15th World Conference on Lung Cancer our objectives are to:

• Enhance tobacco control and smoking cessation
• Identify effective global lung cancer prevention strategies
• Understand risk stratification for screening and early detection
• Utilise optimal biopsy and molecular testing strategies to support individualized care
• Optimize cost-effective imaging for diagnosis, staging and follow-up
• Describe best practice multi-disciplinary management and identify barriers to its implementation
• Appreciate emerging technologies and recent advances in treatment for lung cancer
• Highlight optimal symptom relief and palliation strategies for thoracic cancers
• Practice survivorship and support strategies

CONFERENCE SECRETARIAT

International Conference Services Ltd.
Suite 2101 - 1177 West Hastings Street
Vancouver, BC Canada V6E 2K3
Phone: +1 604 681 2153
Fax: +1 604 681 1049
Email: WCLC2013@icsevents.com

Conference Manager: Grit Schoenherr